Search

everythinglearnresearchcommunity

for

Search:↓

The document praises a resource on hair growth disorders and recognizes a reference on blood diseases' molecular aspects as authoritative.

Black women with CCCA are more likely to have uterine fibroids.

Oral minoxidil helps hair growth but has more side effects than the topical version.

Minoxidil ingestion can raise liver enzyme levels.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

Men with male pattern baldness have increased arterial stiffness.

Using a cotton-tipped applicator as a base for cutting sutures helps make them a uniform length and reduces the risk of skin cuts.

The book is a detailed guide on hair growth issues and treatments, recommended for specialists and hospital libraries.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

In Pakistan, men with more severe hair loss often have a higher BMI.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.